Pharma cos opt for inlicensing to push sales

Image
P B Jayakumar Mumbai
Last Updated : Jan 29 2013 | 12:59 AM IST

Company

Brand

Collaborator

Disease

Ranbaxy

Bonista

Virchow Biotech

Osteoporosis

Inersan

CD Pharma

dental pain

Dr Reddy's

Supanac

Applied Pharma

pain management

Wockhardt

SAMe

Gnosis SpA

osteoporosis

Zindaclin

Crawford Healthcare

acne

B-Lift range

Syrio Pharma

dermatology


*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: May 15 2008 | 12:00 AM IST

Next Story